REQUEST A DEMO
Total
USD $0.00
Search more companies

Angelini Pharma Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Miscellaneous Food Manufacturing | Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | Merchant Wholesalers, Durable Goods | Warehousing and Storage | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising, Public Relations, and Related Services | Advertising Agencies | Convention and Trade Show Organizers
Full name: Angelini Pharma Polska Sp. z o.o. Profile Updated: October 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Angelini Pharma Polska is a pharmaceutical company. They offer modern, molecularly targeted third-generation drugs for cancer treatment, products for infectious diseases and mental health, and are involved in social campaigns for epilepsy awareness and drug resistance. Angelini Pharma Polska has implemented a safety monitoring system for their products.

Headquarters
Ul. Aleje Jerozolimskie 181B
Warsaw; Mazowieckie; Postal Code: 02-222

Contact Details: Purchase the Angelini Pharma Polska Sp. z o.o. report to view the information.

Website: http://www.angelini.pl

Basic Information
Total Employees:
Purchase the Angelini Pharma Polska Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Angelini Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Angelini Pharma Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Angelini Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
June 25, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
W Organie Czlonek Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Angelini Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.51%
Total operating revenue
14.39%
Operating profit (EBIT)
-35.14%
EBITDA
-33.03%
Net Profit (Loss) for the Period
-22.97%
Total assets
16.78%
Total equity
-5.32%
Operating Profit Margin (ROS)
-2.14%
Net Profit Margin
-1.41%
Return on Equity (ROE)
-4.31%
Debt to Equity Ratio
-0.07%
Quick Ratio
-0.18%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?